MedTrace Logo

A Prospective Diagnostic Belief Updating Study to verIfy the Utility of BioEP in First Seizure Clinics.

NCT05764252 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2024-08-12

No results posted yet for this study

Summary

The goal of this belief updating study is to assess the utility of BioEP as a complementary support tool in aiding clinical decision making in adults in first seizure clinics. The main outcomes we shall measure are:

* Clinicians' perception of seizure probability.
* Clinicians' decision to recommend commencing or deferring ASM (anti-seizure medications)
* Clinicians' decision to refer for additional investigations/services.

Participants will consent to have their EEG (that is taken at their routine care) to be used in the study. There is not extra burden to the participants taking part in the study.

Conditions

Interventions

DEVICE

BioEP

All patient's EEG will have the BioEP score conducted on it

Sponsors & Collaborators

  • Neuronostics Ltd

    lead INDUSTRY

Principal Investigators

  • Milaana Mainstone · Neuronostics Ltd

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-23
Primary Completion
2024-08-07
Completion
2025-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05764252 on ClinicalTrials.gov